Civil Society Involvement in Drug Policy – Assessment Report Civil Society Involvement in Drug Policy in EU Member States

On the European Union level, the issue of how to strengthen the civil society involvement (CSI) in drug policy has increasingly attracted attention over the last few years, starting with the presentation of the “Green Paper on the role of Civil Society in Drugs Policy in the European Union” by the European Commission (2006) and the subsequent establishment of the “Civil Society Forum on Drugs” as a platform for regular dialogue on policy development and implementation between the Commission and representatives of European civil society. How the Civil Society Forum on Drugs is to be involved in EU drugs policy is further defined in the current EU Action Plan on Drugs 2017-2020 (Council of Europe 2017). However, the current action plan does not only refer to civil society involvement on the EU level, but also calls for action on the national level to “promote and strengthen dialogue with, and involvement of, civil society and the scientific community in the formulation, implementation, monitoring and evaluation of drug policies”. The successful implementation of best practice in drug demand reduction in the member states, is further hinged (among other indicators) on the “involvement of civil society in the implementation of the standards, including in planning and introduction”.

More info (CSIDP’s website)

Some figures from the report :

Twitter Facebook LinkedIn Pinterest Email